Comprehensive Regulatory Analysis of Contract Research Expense Proration within the Massachusetts Research and Development Tax Credit Framework

Contract Research Expenses (Prorated in Massachusetts) refer to the 65% portion of payments made to third-party contractors for qualified research activities, mathematically adjusted to include only those services performed or tangible assets utilized physically within the Commonwealth’s borders.1 This specialized proration mechanism serves as the primary jurisdictional filter used by the Massachusetts Department of Revenue to ensure that the 10% research and development tax credit specifically incentivizes economic investment and technical innovation occurring at research facilities located in Massachusetts.4

The Massachusetts Research Credit, established under Massachusetts General Laws Chapter 63, Section 38M, represents a sophisticated fiscal instrument designed to attract high-technology enterprises, foster life sciences innovation, and support advanced manufacturing.4 While the credit is modeled closely after the federal research credit found in Internal Revenue Code Section 41, it introduces a critical geographic constraint: only expenditures attributable to research conducted within Massachusetts qualify for the incentive.8 This divergence necessitates a granular level of expense tracking, particularly for contract research, where service providers often operate across state lines. The proration process is not merely an accounting preference but a statutory requirement detailed in the Commonwealth’s regulatory code, specifically 830 CMR 63.38M.1 and 63.38M.2.2 As the Massachusetts innovation economy continues to evolve, understanding the nuances of how these expenses are identified, calculated, and defended during Department of Revenue (DOR) audits has become a priority for corporate tax departments and financial planners.8

The Legislative Architecture of M.G.L. c. 63, § 38M

The legal foundation for the Massachusetts Research Credit is rooted in the Commonwealth’s effort to remain competitive with other high-innovation states. M.G.L. c. 63, § 38M allows domestic and foreign corporations subject to the corporate excise tax to claim a credit for a percentage of their qualified research expenses.5 The statute defines “Qualified Research Expenses” (QREs) as having the same meaning as under Section 41 of the Internal Revenue Code, but with the additional proviso that such expenses must be incurred for research activity conducted in Massachusetts.2 This “Massachusetts-only” requirement is the catalyst for the proration rules that apply to contract research.1

The evolution of the statute has seen significant amendments, most notably the Economic Development Act of 2014, which introduced the Alternative Simplified Method (ASM) for tax years beginning on or after January 1, 2015.4 This amendment allowed businesses to choose a calculation method that mirrors the federal Alternative Simplified Credit (ASC), providing a more accessible path for companies with fluctuating research budgets or those that lack historical data from the 1980s base period.4 Despite these updates to the calculation method, the fundamental requirement for in-state performance remains unchanged. Whether a company elects the Traditional Method or the ASM, the definition of what constitutes a Massachusetts QRE—and the necessity of prorating out-of-state contract work—remains a constant regulatory pillar.14

Defining the Geographic Boundary: The Massachusetts Research Facility Standard

At the heart of the proration requirement is the definition of a “Research Facility Located in Massachusetts.” Under 830 CMR 63.38M.1(2), this is defined as a site physically situated within the geographic borders of the Commonwealth used to conduct qualified or basic research.2 The location of the taxpayer’s headquarters or the place where the contract was signed is irrelevant; the credit focuses exclusively on where the technical work is performed.2

This site-specific focus creates a complex compliance environment for Contract Research Organizations (CROs) and the companies that hire them. For a contract research expense to be considered “attributable to research activity conducted at a research facility located in Massachusetts,” the taxpayer must demonstrate that the third party utilized Massachusetts-based assets or labor.2 If a contractor performs 50% of the research in a lab in Cambridge and 50% in a lab in New Hampshire, only the Cambridge portion enters the Massachusetts QRE pool.1 This distinction is critical because, unlike federal law which allows research conducted anywhere in the United States, Massachusetts aggressively “uncouples” from federal geographic broadness to protect its own tax base.6

Deconstructing Contract Research Expenses: The 65 Percent Limitation

Contract research expenses represent payments to non-employees to perform qualified research. Under both the Internal Revenue Code (IRC § 41(b)(3)) and Massachusetts law (M.G.L. c. 63, § 38M), only 65% of these payments are eligible for the credit.1 This “haircut” is designed to account for the overhead, administrative costs, and profit margins that contractors typically include in their billing, which do not represent direct research expenditures.16

For Massachusetts purposes, the 65% rule is applied before or in conjunction with the geographic proration. The Department of Revenue’s Schedule RC (Research Credit) specifically instructs taxpayers on Line 4 to enter “65% of qualified contract expenses”.17 This line serves as the repository for all third-party research spending that has already been filtered through the Massachusetts performance test.14 It is important to note that this category is distinct from “Basic Research Payments,” which are typically made to universities or non-profit research organizations and may be eligible for a higher 15% credit rate under the Traditional Method, although they often involve their own unique 65% limitations in specific sub-calculations.2

The Proration Mandate: Temporal and Spatial Allocation Methodologies

When research services are performed both within and outside Massachusetts, the Department of Revenue requires a formal proration based on a “ratio of days” methodology.1 This rule, found in 830 CMR 63.38M.1(4)(b)4, applies to both personal services (the labor of the contractor) and the use of tangible personal property (equipment or specialized lab assets).1

The General Proration Formula: Ratio of Days

The standard approach for allocating contract research expenses involves tracking the number of days the service provider or property was utilized in Massachusetts relative to the total duration of the research project.1

$$\text{Prorated Massachusetts Expense} = (\text{Total Qualified Contract Payment} \times 0.65) \times \frac{\text{Days Employed in Massachusetts}}{\text{Total Days Employed}}$$

In this calculation, the “Days Employed in Massachusetts” serves as the numerator, representing the period during which the contractor was physically present at a Massachusetts research facility or the equipment was operating within the state.1 The denominator reflects the total number of days the contractor or property was dedicated to the research project, regardless of location.1

The Field Research Exception: Facility-Based Apportionment

A specialized proration rule exists for “field research,” which often involves data collection or testing conducted outside of a fixed laboratory environment. According to guidance provided by the DOR, if the results of field research (such as environmental sampling or multi-site clinical trials) are intended to be utilized at research facilities both within and outside of Massachusetts, a different apportionment fraction is required.3

For field research, the numerator is the number of research facilities located in Massachusetts where the results of the field research will be used.3 The denominator is the total number of research facilities (wherever located) where those results will be utilized.3 This ensures that even if the physical testing occurs in a neutral or out-of-state “field” location, the taxpayer can still claim a portion of the credit based on the “intellectual destination” of the research findings.3

Regulatory Guidance and the Evolutionary Role of Technical Information Releases

The Massachusetts Department of Revenue utilizes Technical Information Releases (TIRs) and Letter Rulings to provide essential clarity on how the research credit statute (M.G.L. c. 63, § 38M) applies to specific business scenarios. These documents are vital for taxpayers because they often address administrative changes that have not yet been codified into formal regulations.

TIR 14-13 and TIR 14-16: The Implementation of the ASM

One of the most significant shifts in the history of the Massachusetts Research Credit was the introduction of the Alternative Simplified Method. TIR 14-13 provided the initial guidance on the Economic Development Act of 2014, explaining that businesses could now choose between the Traditional Method and the ASM.4 TIR 14-16 followed as a supplemental budget correction, clarifying that the ASM rate would be phased in over several years.5

These TIRs are fundamental to the proration discussion because they established that the “base amount” for the ASM is calculated using only Massachusetts-qualified expenses from the three preceding years.14 This means that if a company failed to properly prorate its contract research expenses in 2021-2023, its “base amount” for a 2024 credit claim could be artificially inflated or deflated, leading to significant audit risk.8

TIR 04-15: Research and Development Corporations vs. Credits

TIR 04-15 serves as a critical document for understanding the distinction between a company that merely claims the research credit and a “Research and Development Corporation” as defined under M.G.L. c. 63, §§ 38C and 42B.18 To be classified as an R&D corporation—which grants access to additional benefits like sales tax exemptions on machinery and equipment—the entity must meet a “receipts test” or an “expenditures test”.18

Specifically, the entity must either derive more than two-thirds of its Massachusetts-attributable receipts from R&D or incur more than two-thirds of its Massachusetts-attributable expenditures for R&D.18 This “two-thirds” threshold is assessed annually and relies heavily on the same proration principles used for the research credit.18 For instance, a CRO operating in Massachusetts must carefully track its prorated in-state expenditures to ensure it maintains its status as an R&D corporation, thereby exempting its purchase of expensive laboratory equipment from the 6.25% state sales tax.18

TIR 25-3: Recent Guidance for Financial Institutions

Looking ahead to 2025, the Department of Revenue released TIR 25-3, which confirmed the eligibility of financial institutions to claim the research credit.8 Historically, financial institutions were often excluded from certain corporate credits due to their unique taxation under separate chapters of the General Laws. This recent guidance confirms that financial institutions engaging in qualified research (such as developing innovative fintech software or high-security banking protocols at Massachusetts facilities) can utilize the 38M credit, provided they adhere to the same proration and performance standards as general business corporations.8

Comparative Analysis of Calculation Methodologies: Traditional vs. Alternative Simplified

Taxpayers in Massachusetts must navigate a strategic choice between two calculation methods. While both require the same geographic proration of contract research expenses, they differ significantly in how they establish the threshold for what constitutes “incremental” research.

Option 1: The Traditional Method (M.G.L. c. 63, § 38M(a))

The Traditional Method is a legacy calculation that compares current research spending against a historical base. It is generally more beneficial for companies that have maintained a consistent or slowly growing R&D presence in Massachusetts since the late 1980s.15

• Credit Amount: 10% of current year Massachusetts QREs that exceed the “base amount,” plus 15% of basic research payments.2
• Base Amount: The product of the company’s “fixed-base ratio” and its average annual gross receipts for the four preceding taxable years.11
• Fixed-Base Ratio: For years beginning after 2015, this is a rolling ratio determined by taking the total Massachusetts QREs for the third and fourth taxable years preceding the credit year and dividing by the total gross receipts for those same two years.14
• Minimum Threshold: In no event can the base amount be less than 50% of the current year’s Massachusetts QREs.2

Option 2: The Alternative Simplified Method (M.G.L. c. 63, § 38M(b))

The ASM is a more dynamic calculation that focuses on recent spending trends rather than historical receipts. It is often the preferred choice for startups, companies with erratic revenue, or those that have recently expanded their Massachusetts operations.4

• Credit Amount: 10% of current year Massachusetts QREs that exceed 50% of the average Massachusetts QREs for the three preceding taxable years.4
• Ease of Entry: If a company did not have any research expenses in the three prior years, the credit is simply 5% of the current year’s Massachusetts QREs.4
• Strategic Limitation: Taxpayers electing the ASM do not receive the 15% basic research payment add-on.8

Corporate Excise Limitations and the Carryforward Architecture

Claiming the credit is only the first step; the second is effectively utilizing it to offset tax liability. Massachusetts imposes strict limitations on how much credit can be taken in any single tax year to ensure that every corporation pays at least a minimum contribution to the Commonwealth’s general fund.

The $456 Statutory Minimum Tax

The research credit is non-refundable (except for specific life sciences programs) and cannot be used to reduce a corporation’s excise liability below the statutory minimum tax, which is currently $456.4 This floor ensures that even a company with massive R&D credits must maintain a nominal tax presence.5

The $25,000 Threshold and the 75 Percent Cap

Beyond the minimum tax floor, the credit is limited by a two-tiered threshold based on the corporation’s pre-credit excise liability 4:

1. First $25,000: The credit can offset 100% of the first $25,000 of corporate excise.4
2. Excess over $25,000: For any excise liability exceeding $25,000, the credit can only offset up to 75% of that additional amount.4

Carryforward Provisions: Safeguarding Unused Credits

When the aforementioned limitations prevent a corporation from using its full credit amount, the remaining balance can be carried forward to future tax years. Massachusetts provides a generous carryforward timeline that distinguishes between different types of disallowed credits.5

• Standard Carryforward (15 Years): Credits that exceed the total tax liability or are simply unused can be carried forward for 15 years.4
• Indefinite Carryforward: Any portion of the credit that was disallowed specifically due to the “75% of excise over $25,000” limitation can be carried forward indefinitely.5 This provision is particularly valuable for large corporations with sustained research programs that consistently generate more credits than they can immediately absorb.

The Life Sciences Nexus: MLSC Incentives and Refundability

Massachusetts is uniquely positioned as a global leader in life sciences, and the Commonwealth’s tax code reflects this priority through the Massachusetts Life Sciences Center (MLSC). The MLSC administers a specialized tax incentive program that interacts deeply with the Section 38M research credit.4

The 90 Percent Refund Election

The most significant benefit for life sciences companies is the ability to request a refund for unused research credits. Under the MLSC program, certified life sciences companies that have generated research credits but lack the tax liability to use them can apply for a refund equal to 90% of the value of the unused credit.10 This is a “cash-in-hand” mechanism that is not available to companies in other sectors, providing vital capital to early-stage biotech and medical device firms.20

Performance and Economic Impact Statistics

The MLSC program’s scale and success are documented in recent transparency reports and economic analyses. As of the 2024-2025 cycle, the impact of these incentives is evident across the Commonwealth’s ecosystem 25:

These statistics highlight the critical role that the research credit plays in the broader “Life Sciences Tax Incentive Program,” which also includes the Life Sciences Investment Tax Credit (10% for property) and the FDA User Fee Credit.10

Audit Preparation and the Documentation Burden

The Department of Revenue maintains a rigorous audit posture regarding research credits. Given the complexity of the proration rules, companies must proactively establish a “defensible file” that can withstand scrutiny several years after the credit is claimed.

Essential Documentation for Contract Research

To defend the proration of contract research expenses, a taxpayer should maintain the following records 8:

• Contemporary Location Logs: Records maintained by the contractor indicating exactly which days were spent at a Massachusetts research facility versus other locations.3
• Qualified Research Project Descriptions: Documentation that links the contract work to a specific “business component” and proves it meets the IRS Four-Part Test (Technological in Nature, Permitted Purpose, Elimination of Uncertainty, and Process of Experimentation).20
• Contracts and SOWs: Detailed Statements of Work (SOW) that explicitly state the research nature of the services and ideally designate the Massachusetts facility as the primary site of performance.3
• Proration Worksheets: A clear, mathematical explanation of how the 65% limitation was applied and how the “ratio of days” fraction was derived.27

The Impact of Federal Form 6765 Changes

In late 2024, the IRS released updates to Form 6765, which is used to claim the federal R&D credit. These changes mandate significantly more qualitative data, including business component-level reporting.26 While these are federal changes, the Massachusetts DOR typically follows federal lead on documentation standards. Taxpayers should anticipate that the DOR may soon require similar business-component level detail on Massachusetts Schedule RC, making the need for precise, prorated data even more acute.26

Comprehensive Mathematical Models and Industry Scenarios

To demonstrate the practical application of the Massachusetts proration and credit calculation, let us examine a detailed scenario involving a hypothetical firm, “Cambridge Robotics Corp.”

Scenario: Cambridge Robotics Corp. (Tax Year 2024)

• Entity Status: Massachusetts Domestic Corporation.
• Method Election: Alternative Simplified Method (ASM).
• Excise Liability: $200,000.
• Contract Research Spend: $2,000,000 total paid to an external engineering firm, “NH Labs,” based in New Hampshire.
• Work Summary: “NH Labs” provided 1,000 total hours of service. Logbooks show that 600 hours were performed on-site at Cambridge Robotics’ facility in Massachusetts using specialized testing rigs. The remaining 400 hours were spent at “NH Labs” in New Hampshire.
• Prior 3-Year QRE Average: $1,200,000.

Step 1: Calculate the Prorated Massachusetts QRE

First, we apply the 65% statutory limitation to the total contract payment:

$$\$2,000,000 \times 0.65 = \$1,300,000$$

Second, we determine the geographic proration using the ratio of work performed in Massachusetts. Although the regulation mentions “days,” hours are a common and accepted proxy for “ratio of days” in audit practice, provided the record is consistent:

$$\text{Prorated Expense} = \$1,300,000 \times \left( \frac{600 \text{ hours in MA}}{1,000 \text{ total hours}} \right)$$

$$\text{Prorated Expense} = \$1,300,000 \times 0.60 = \$780,000$$

Step 2: Determine the Incremental Credit under ASM

Following the ASM formula for 2024 8:

• Current MA QRE (Line 6): $780,000.
• Average Prior QREs (Line 7): $1,200,000.
• Base Amount (Line 8, 50% of Line 7): $600,000.
• Excess QREs (Line 9): $\$780,000 – \$600,000 = \$180,000$.
• Credit Amount (Line 11, 10% of Excess): $\$18,000$.

Step 3: Application against Corporate Excise Liability

• Gross Excise: $200,000.
• First $25,000 Offset (100%): $25,000 available capacity.
• Remaining Excise: $175,000.
• Second Bracket Limit (75%): $\$175,000 \times 0.75 = \$131,250$ available capacity.
• Total Capacity: $\$25,000 + \$131,250 = \$156,250$.

Since the generated credit of $18,000 is far below the total capacity of $156,250 and leaves the excise liability ($182,000) well above the $456 minimum tax, the company can utilize the full $18,000 in the current tax year.

Future Horizons: 2025 Updates and Federal Conformity

As of the 2025 tax cycle, several key developments are reshaping the landscape for Massachusetts taxpayers. The confirmance of financial institutions as eligible claimants via TIR 25-3 marks a significant expansion of the credit’s reach, potentially bringing hundreds of new companies into the compliance fold.8 Additionally, the expansion of the “defense-related activities” definition to include biological products and medical supplies for radiological or nuclear threats provides a strategic path for life sciences companies to claim the 10% credit under the Traditional Method, even if their overall spending doesn’t meet standard growth thresholds.14

The continuing divergence between Massachusetts and federal law on the “Section 174 capitalization” issue remains a point of friction. While the federal “One Big Beautiful Bill” (OBBB) and other legislative efforts have attempted to repeal or delay the requirement to amortize R&D costs over 5 years (15 years for foreign R&D), Massachusetts currently requires companies to capitalize their R&E costs for income measure purposes, though this does not directly alter the calculation of the research credit itself.16 Taxpayers must remain vigilant, as the interplay between amortization and credit generation creates multi-year cash flow implications that require sophisticated tax modeling.

Final Synthesis and Recommendations

The concept of “Contract Research Expenses (Prorated in Massachusetts)” represents a fundamental junction where technical innovation meets jurisdictional tax sovereignty. For businesses operating in the Commonwealth, the 10% research credit offers a substantial opportunity to offset the high costs of R&D labor and facilities. However, the benefit is contingent upon the taxpayer’s ability to prove that the activity was physically conducted within Massachusetts.

By adhering to the “ratio of days” methodology and maintaining meticulous records of contractor locations, companies can successfully navigate the complexities of M.G.L. c. 63, § 38M. The choice between the Traditional Method and the Alternative Simplified Method remains a strategic decision that depends on historical spending patterns and revenue stability. As the Department of Revenue continues to refine its guidance through TIRs and updated regulations, and as the MLSC continues to support the life sciences sector with refundable credits, the Massachusetts Research Credit remains one of the most powerful economic development tools in the northeastern United States. Business leaders and tax professionals are encouraged to treat the proration of contract research not as an administrative burden, but as a critical component of a proactive and defensible tax strategy that fuels long-term growth and technical excellence.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/